JY BioMed is led by a multidisciplinary team of scientific, clinical, and strategic experts committed to translating research into real-world impact. With decades of combined experience across immunotherapy, regenerative medicine, and biologic drug development, our leadership is focused on building robust, scalable platforms that can meet both medical and regulatory standards.